To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.
Status:
Completed
Trial end date:
2018-01-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether LJN452 improves the symptoms of bile acid
diarrhea and to assess its safety and tolerability profile in patients with primary bile acid
diarrhea (pBAD) to guide decision-making regarding further clinical development in this
indication.